CALIFORNIA LIFE SCIENCES ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FORBES-TATE	—	25

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	24
SENATE	24

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Trade (domestic/foreign)	Trade (domestic/foreign)	25
Pharmacy	Pharmacy	25
Health Issues	Health Issues	25
Medicare/Medicaid	Medicare/Medicaid	25
Manufacturing	Manufacturing	25
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	25
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	25

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

Show 21 more cited filings

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · second_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2023 · first_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · fourth_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

H.R. 5376117th Congress

Inflation Reduction Act of 2022

2022 · third_quarter · Firm: FORBES-TATE

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the life sciences industry; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).

Client expense: — · Firm income: $40,000

Matched citations: H.R. 5376

Source: Senate LDA

CALIFORNIA LIFE SCIENCES ASSOCIATION — Lobbying Disclosure | Poliscope